|
ICD10
|
ICD 10 Description
|
Age Limit
|
|
B20
|
Human immunodeficiency virus (HIV) disease
|
0—20
|
|
C96.0
|
Multifocal and multisystemic Langerhans-cell histiocytosis
|
0—64
|
|
C96.5
|
Multifocal and unisystemic Langerhans-cell histiocytosis
|
0—64
|
|
C96.6
|
Unifocal Langerhans-cell histiocytosis
|
0—64
|
|
D61.01
|
Constitutional (pure) red blood cell aplasia
|
0—20
|
|
D61.09
|
Other constitutional aplastic anemia
|
0—20
|
|
D66
|
Hereditary factor VIII deficiency
|
0—64
|
|
D67
|
Hereditary factor IX deficiency
|
0—64
|
|
D68.00
|
Von Willebrand disease, unspecified
|
0—64
|
|
D68.01
|
Von Willebrand disease, type 1
|
0—64
|
|
D68.020
|
Von Willebrand disease, type 2A
|
0—64
|
|
D68.021
|
Von Willebrand disease, type 2B
|
0—64
|
|
D68.022
|
Von Willebrand disease, type 2M
|
0—64
|
|
D68.023
|
Von Willebrand disease, type 2N
|
0—64
|
|
D68.029
|
Von Willebrand disease, type 2, unspecified
|
0—64
|
|
D68.03
|
Von Willebrand disease, type 3
|
0—64
|
|
D68.04
|
Acquired von Willebrand disease
|
0—64
|
|
D68.09
|
Other von Willebrand disease
|
0—64
|
|
D68.1
|
Hereditary factor XI deficiency
|
0—64
|
|
D68.2
|
Hereditary deficiency of other clotting factors
|
0—64
|
|
E70.0
|
Classical phenylketonuria
|
0—20
|
|
E70.1
|
Other hyperphenylalaninemias
|
0—20
|
|
E70.20
|
Disorder of tyrosine metabolism, unspecified
|
0—20
|
|
E70.21
|
Tyrosinemia
|
0—20
|
|
E70.29
|
Other disorders of tyrosine metabolism
|
0—20
|
|
E70.30
|
Albinism, unspecified
|
0—20
|
|
E70.40
|
Disorders of histidine metabolism, unspecified
|
0—20
|
|
E70.41
|
Histidinemia
|
0—20
|
|
E70.49
|
Other disorders of histidine metabolism
|
0—20
|
|
E70.5
|
Disorders of tryptophan metabolism
|
0—20
|
|
E70.81
|
Aromatic L-amino acid decarboxylase deficiency
|
0—20
|
|
E70.89
|
Other disorders of amino-acid metabolism
|
0—20
|
|
E71.110
|
Isovaleric acidemia
|
0—20
|
|
E71.111
|
3-methylglutaconic aciduria
|
0—20
|
|
E71.118
|
Other branched-chain organic acidurias
|
0—20
|
|
E71.120
|
Methylmalonic acidemia
|
0—20
|
|
E71.121
|
Propionic acidemia
|
0—20
|
|
E71.128
|
Other disorders of propionate metabolism
|
0—20
|
|
E71.19
|
Other disorders of branched-chain amino-acid metabolism
|
0—20
|
|
E71.2
|
Disorder of branched-chain amino-acid metabolism, unspecified
|
0—20
|
|
E71.310
|
Long chain/very long chain acyl CoA dehydrogenase deficiency
|
0—64
|
|
E71.311
|
Medium chain acyl CoA dehydrogenase deficiency
|
0—64
|
|
E71.312
|
Short chain acyl CoA dehydrogenase deficiency
|
0—64
|
|
E71.313
|
Glutaric aciduria type II
|
0—64
|
|
E71.314
|
Muscle carnitine palmitoyltransferase deficiency
|
0—64
|
|
E71.318
|
Other disorders of fatty-acid oxidation
|
0—64
|
|
E71.32
|
Disorders of ketone metabolism
|
0—64
|
|
E71.39
|
Other disorders of fatty-acid metabolism
|
0—64
|
|
E71.41
|
Primary carnitine deficiency
|
0—64
|
|
E71.42
|
Carnitine deficiency due to inborn errors of metabolism
|
0—64
|
|
E71.50
|
Peroxisomal disorder, unspecified
|
0—64
|
|
E71.510
|
Zellweger syndrome
|
0—64
|
|
E71.511
|
Neonatal adrenoleukodystrophy
|
0—64
|
|
E71.518
|
Other disorders of peroxisome biogenesis
|
0—64
|
|
E71.520
|
Childhood cerebral X-linked adrenoleukodystrophy
|
0—64
|
|
E71.521
|
Adolescent X-linked adrenoleukodystrophy
|
0—64
|
|
E71.522
|
Adrenomyeloneuropathy
|
0—64
|
|
E71.528
|
Other X-linked adrenoleukodystrophy
|
0—64
|
|
E71.529
|
X-linked adrenoleukodystrophy, unspecified type
|
0—64
|
|
E71.53
|
Other group 2 peroxisomal disorders
|
0—64
|
|
E71.540
|
Rhizomelic chondrodysplasia punctata
|
0—64
|
|
E71.541
|
Zellweger-like syndrome
|
0—64
|
|
E71.542
|
Other group 3 peroxisomal disorders
|
0—64
|
|
E71.548
|
Other peroxisomal disorders
|
0—64
|
|
E72.01
|
Cystinuria
|
0—20
|
|
E72.02
|
Hartnup’s disease
|
0—20
|
|
E72.03
|
Lowe’s syndrome
|
0—20
|
|
E72.04
|
Cystinosis
|
0—20
|
|
E72.09
|
Other disorders of amino-acid transport
|
0—20
|
|
E72.11
|
Homocystinuria
|
0—20
|
|
E72.12
|
Methylenetetrahydrofolate reductase deficiency
|
0—20
|
|
E72.19
|
Other disorders of sulfur-bearing amino-acid metabolism
|
0—20
|
|
E72.20
|
Disorder of urea cycle metabolism, unspecified
|
0—20
|
|
E72.21
|
Argininemia
|
0—20
|
|
E72.22
|
Arginosuccinic aciduria
|
0—20
|
|
E72.23
|
Citrullinemia
|
0—20
|
|
E72.29
|
Other disorders of urea cycle metabolism
|
0—20
|
|
E72.3
|
Disorders of lysine and hydroxylysine metabolism
|
0—20
|
|
E72.4
|
Disorders of ornithine metabolism
|
0—20
|
|
E72.51
|
Non-ketotic hyperglycinemia
|
0—20
|
|
E72.52
|
Trimethylaminuria
|
0—20
|
|
E72.53
|
Primary hyperoxaluria
|
0—20
|
|
E72.59
|
Other disorders of glycine metabolism
|
0—20
|
|
E72.81
|
Disorders of gamma aminobutyric acid metabolism
|
0—20
|
|
E72.89
|
Other specified disorders of amino-acid metabolism
|
0—20
|
|
E74.00
|
Glycogen storage disease, unspecified
|
0—20
|
|
E74.01
|
von Gierke disease
|
0—20
|
|
E74.02
|
Pompe disease
|
0—20
|
|
E74.03
|
Cori disease
|
0—20
|
|
E74.04
|
McArdle disease
|
0—20
|
|
E74.09
|
Other glycogen storage disease
|
0—20
|
|
E74.12
|
Hereditary fructose intolerance
|
0—20
|
|
E74.19
|
Other disorders of fructose metabolism
|
0—20
|
|
E74.21
|
Galactosemia
|
0—20
|
|
E74.29
|
Other disorders of galactose metabolism
|
0—20
|
|
E74.4
|
Disorders of pyruvate metabolism and gluconeogenesis
|
0—20
|
|
E75.00
|
GM2 gangliosidosis, unspecified
|
0—20
|
|
E75.01
|
Sandhoff disease
|
0—20
|
|
E75.02
|
Tay-Sachs disease
|
0—20
|
|
E75.09
|
Other GM2 gangliosidosis
|
0—20
|
|
E75.10
|
Unspecified gangliosidosis
|
0—20
|
|
E75.11
|
Mucolipidosis IV
|
0—20
|
|
E75.19
|
Other gangliosidosis
|
0—20
|
|
E75.21
|
Fabry (-Anderson) disease
|
0—20
|
|
E75.22
|
Gaucher disease
|
0—20
|
|
E75.23
|
Krabbe disease
|
0—20
|
|
E75.242
|
Niemann-Pick disease type C
|
0—20
|
|
E75.243
|
Niemann-Pick disease type D
|
0—20
|
|
E75.244
|
Niemann-Pick disease type A/B
|
0—20
|
|
E75.25
|
Metachromatic leukodystrophy
|
0—20
|
|
E75.26
|
Sulfatase deficiency
|
0—20
|
|
E75.29
|
Other sphingolipidosis
|
0—20
|
|
E75.3
|
Sphingolipidosis, unspecified
|
0—20
|
|
E75.4
|
Neuronal ceroid lipofuscinosis
|
0—20
|
|
E75.5
|
Other lipid storage disorders
|
0—20
|
|
E76.01
|
Hurler’s syndrome
|
0—64
|
|
E76.02
|
Hurler-Scheie syndrome
|
0—64
|
|
E76.03
|
Scheie’s syndrome
|
0—64
|
|
E76.1
|
Mucopolysaccharidosis, type II
|
0—64
|
|
E76.210
|
Morquio A mucopolysaccharidoses
|
0—64
|
|
E76.211
|
Morquio B mucopolysaccharidoses
|
0—64
|
|
E76.219
|
Morquio mucopolysaccharidoses, unspecified
|
0—64
|
|
E76.22
|
Sanfilippo mucopolysaccharidoses
|
0—64
|
|
E76.29
|
Other mucopolysaccharidoses
|
0—64
|
|
E76.3
|
Mucopolysaccharidosis, unspecified
|
0—64
|
|
E76.8
|
Other disorders of glucosaminoglycan metabolism
|
0—64
|
|
E77.0
|
Defects in post-translational mod of lysosomal enzymes
|
0—20
|
|
E77.1
|
Defects in glycoprotein degradation
|
0—20
|
|
E77.8
|
Other disorders of glycoprotein metabolism
|
0—20
|
|
E79.1
|
Lesch-Nyhan syndrome
|
0—64
|
|
E79.2
|
Myoadenylate deaminase deficiency
|
0—64
|
|
E79.8
|
Other disorders of purine and pyrimidine metabolism
|
0—64
|
|
E79.9
|
Disorder of purine and pyrimidine metabolism, unspecified
|
0—64
|
|
E80.3
|
Defects of catalase and peroxidase
|
0—64
|
|
E84.0
|
Cystic fibrosis with pulmonary manifestations
|
0—64
|
|
E84.11
|
Meconium ileus in cystic fibrosis
|
0—64
|
|
E84.19
|
Cystic fibrosis with other intestinal manifestations
|
0—64
|
|
E84.8
|
Cystic fibrosis with other manifestations
|
0—64
|
|
E84.9
|
Cystic fibrosis, unspecified
|
0—64
|
|
E88.40
|
Mitochondrial metabolism disorder, unspecified
|
0—64
|
|
E88.41
|
MELAS syndrome
|
0—64
|
|
E88.42
|
MERRF syndrome
|
0—64
|
|
E88.49
|
Other mitochondrial metabolism disorders
|
0—64
|
|
E88.89
|
Other specified metabolic disorders
|
0—64
|
|
F84.2
|
Rett’s syndrome
|
0—20
|
|
G11.0
|
Congenital nonprogressive ataxia
|
0—20
|
|
G11.10
|
Early-onset cerebellar ataxia, unspecified
|
0—20
|
|
G11.11
|
Friedreich ataxia
|
0—20
|
|
G11.19
|
Other early-onset cerebellar ataxia
|
0—20
|
|
G11.2
|
Late-onset cerebellar ataxia
|
0—20
|
|
G11.3
|
Cerebellar ataxia with defective DNA repair
|
0—20
|
|
G11.4
|
Hereditary spastic paraplegia
|
0—20
|
|
G11.8
|
Other hereditary ataxias
|
0—20
|
|
G11.9
|
Hereditary ataxia, unspecified
|
0—20
|
|
G12.0
|
Infantile spinal muscular atrophy, type I (Werdnig-Hoffman)
|
0—20
|
|
G12.1
|
Other inherited spinal muscular atrophy
|
0—20
|
|
G12.21
|
Amyotrophic lateral sclerosis
|
0—20
|
|
G12.22
|
Progressive bulbar palsy
|
0—20
|
|
G12.29
|
Other motor neuron disease
|
0—20
|
|
G12.8
|
Other spinal muscular atrophies and related syndromes
|
0—20
|
|
G12.9
|
Spinal muscular atrophy, unspecified
|
0—20
|
|
G24.1
|
Genetic torsion dystonia
|
0—64
|
|
G24.8
|
Other dystonia
|
0—64
|
|
G25.3
|
Myoclonus
|
0—5
|
|
G25.9
|
Extrapyramidal and movement disorder, unspecified
|
0—20
|
|
G31.81
|
Alpers disease
|
0—20
|
|
G31.82
|
Leigh’s disease
|
0—20
|
|
G31.9
|
Degenerative disease of nervous system, unspecified
|
0—20
|
|
G32.81
|
Cerebellar ataxia in diseases classified elsewhere
|
0—20
|
|
G37.0
|
Diffuse sclerosis of central nervous system
|
0—64
|
|
G37.5
|
Concentric sclerosis (Balo) of central nervous system
|
0—64
|
|
G71.00
|
Muscular dystrophy, unspecified
|
0—64
|
|
G71.01
|
Duchenne or Becker muscular dystrophy
|
0—64
|
|
G71.02
|
Facioscapulohumeral muscular dystrophy
|
0—64
|
|
G71.031
|
Autosomal dominant limb girdle muscular dystrophy
|
0—64
|
|
G71.032
|
Autosomal recessive limb girdle muscular dystrophy due to calpain-3 dysfunction
|
0—64
|
|
G71.033
|
Limb girdle muscular dystrophy due to dysferlin dysfunction
|
0—64
|
|
G71.0340
|
Limb girdle muscular dystrophy due to sarcoglycan dysfunction, unspecified
|
0—64
|
|
G71.0341
|
Limb girdle muscular dystrophy due to alpha sarcoglycan dysfunction
|
0—64
|
|
G71.0342
|
Limb girdle muscular dystrophy due to beta sarcoglycan dysfunction
|
0—64
|
|
G71.0349
|
Limb girdle muscular dystrophy due to other sarcoglycan dysfunction
|
0—64
|
|
G71.035
|
Limb girdle muscular dystrophy due to anoctamin-5 dysfunction
|
0—64
|
|
G71.038
|
Other limb girdle muscular dystrophy
|
0—64
|
|
G71.039
|
Limb girdle muscular dystrophy, unspecified
|
0—64
|
|
G71.09
|
Other specified muscular dystrophies
|
0—64
|
|
G71.11
|
Myotonic muscular dystrophy
|
0—64
|
|
G71.20
|
Congenital myopathy, unspecified
|
0—64
|
|
G71.21
|
Nemaline myopathy
|
0—64
|
|
G71.220
|
Centronuclear myopathy
|
0—64
|
|
G71.228
|
Other centronuclear myopathy
|
0—64
|
|
G71.29
|
Other congenial myopathy
|
0—64
|
|
G80.0
|
Spastic quadriplegic cerebral palsy
|
0—64
|
|
G80.1
|
Spastic diplegic cerebral palsy
|
0—20
|
|
G80.3
|
Athetoid cerebral palsy
|
0—64
|
|
G82.50
|
Quadriplegia, unspecified
|
0—64
|
|
G82.51
|
Quadriplegia, C1-C4 complete
|
0—64
|
|
G82.52
|
Quadriplegia, C1-C4 incomplete
|
0—64
|
|
G82.53
|
Quadriplegia, C5-C7 complete
|
0—64
|
|
G82.54
|
Quadriplegia, C5-C7 incomplete
|
0—64
|
|
G91.0
|
Communicating hydrocephalus
|
0—20
|
|
G91.1
|
Obstructive hydrocephalus
|
0—20
|
|
I67.5
|
Moyamoya disease
|
0—64
|
|
K91.2
|
Postsurgical malabsorption, not elsewhere classified
|
0—20
|
|
N03.A
|
Chronic nephritic syndrome with C3 glomerulonephritis
|
0—20
|
|
N03.1
|
Chronic nephritic syndrome with focal and segmental glomerular lesions
|
0—20
|
|
N03.2
|
Chronic nephritic syndrome w diffuse membranous glomrlneph
|
0—20
|
|
N03.3
|
Chronic neph syndrome w diffuse mesangial prolif glomrlneph
|
0—20
|
|
N03.4
|
Chronic neph syndrome w diffuse endocaplry prolif glomrlneph
|
0—20
|
|
N03.5
|
Chronic nephritic syndrome w diffuse mesangiocap glomrlneph
|
0—20
|
|
N03.6
|
Chronic nephritic syndrome with dense deposit disease
|
0—20
|
|
N03.7
|
Chronic nephritic syndrome w diffuse crescentic glomrlneph
|
0—20
|
|
N03.8
|
Chronic nephritic syndrome with other morphologic changes
|
0—20
|
|
N03.9
|
Chronic nephritic syndrome with unspecified morphologic changes
|
0—20
|
|
N08
|
Glomerular disorders in diseases classified elsewhere
|
0—20
|
|
N18.1
|
Chronic kidney disease, stage 1
|
0—20
|
|
N18.2
|
Chronic kidney disease, stage 2 (mild)
|
0—20
|
|
N18.30
|
Chronic kidney disease, stage 3, unspecified
|
0—20
|
|
N18.31
|
Chronic kidney disease, stage 3a
|
0—20
|
|
N18.32
|
Chronic kidney disease, stage 3b
|
0—20
|
|
N18.4
|
Chronic kidney disease, stage 4 (severe)
|
0—20
|
|
N18.5
|
Chronic kidney disease, stage 5
|
0—20
|
|
N18.6
|
End stage renal disease
|
0—20
|
|
N18.9
|
Chronic kidney disease, unspecified
|
0—20
|
|
Q01.9
|
Encephalocele, unspecified
|
0—20
|
|
Q02
|
Microcephaly
|
0—20
|
|
Q03.0
|
Malformations of aqueduct of Sylvius
|
0—20
|
|
Q03.1
|
Atresia of foramina of Magendie and Luschka
|
0—20
|
|
Q03.8
|
Other congenital hydrocephalus
|
0—20
|
|
Q03.9
|
Congenital hydrocephalus, unspecified
|
0—20
|
|
Q04.3
|
Other reduction deformities of brain
|
0—20
|
|
Q04.5
|
Megalencephaly
|
0—20
|
|
Q04.6
|
Congenital cerebral cysts
|
0—20
|
|
Q04.8
|
Other specified congenital malformations of brain
|
0—20
|
|
Q05.0
|
Cervical spina bifida with hydrocephalus
|
0—64
|
|
Q05.1
|
Thoracic spina bifida with hydrocephalus
|
0—64
|
|
Q05.2
|
Lumbar spina bifida with hydrocephalus
|
0—64
|
|
Q05.3
|
Sacral spina bifida with hydrocephalus
|
0—64
|
|
Q05.4
|
Unspecified spina bifida with hydrocephalus
|
0—64
|
|
Q05.5
|
Cervical spina bifida without hydrocephalus
|
0—64
|
|
Q05.6
|
Thoracic spina bifida without hydrocephalus
|
0—64
|
|
Q05.7
|
Lumbar spina bifida without hydrocephalus
|
0—64
|
|
Q05.8
|
Sacral spina bifida without hydrocephalus
|
0—64
|
|
Q05.9
|
Spina bifida, unspecified
|
0—64
|
|
Q06.0
|
Amyelia
|
0—64
|
|
Q06.1
|
Hypoplasia and dysplasia of spinal cord
|
0—64
|
|
Q06.2
|
Diastematomyelia
|
0—64
|
|
Q06.3
|
Other congenital cauda equina malformations
|
0—64
|
|
Q06.4
|
Hydromyelia
|
0—64
|
|
Q06.8
|
Other specified congenital malformations of spinal cord
|
0—64
|
|
Q07.01
|
Arnold-Chiari syndrome with spina bifida
|
0—64
|
|
Q07.02
|
Arnold-Chiari syndrome with hydrocephalus
|
0—64
|
|
Q07.03
|
Arnold-Chiari syndrome with spina bifida and hydrocephalus
|
0—64
|
|
Q30.1
|
Agenesis and underdevelopment of nose, cleft or absent nose only
|
0—5
|
|
Q30.2
|
Fissured, notched and cleft nose, cleft or absent nose only
|
0—5
|
|
Q31.0
|
Web of larynx
|
0—20
|
|
Q31.8
|
Other congenital malformations of larynx, atresia or agenesis of larynx only
|
0—20
|
|
Q32.1
|
Other congenital malformations of trachea, atresia or agenesis of trachea only
|
0—20
|
|
Q32.4
|
Other congenital malformations of bronchus, atresia or agenesis of bronchus only
|
0—20
|
|
Q33.0
|
Congenital cystic lung
|
0—20
|
|
Q33.2
|
Sequestration of lung
|
0—20
|
|
Q33.3
|
Agenesis of lung
|
0—20
|
|
Q33.6
|
Congenital hypoplasia and dysplasia of lung
|
0—20
|
|
Q35.1
|
Cleft hard palate
|
0—20
|
|
Q35.3
|
Cleft soft palate
|
0—20
|
|
Q35.5
|
Cleft hard palate with cleft soft palate
|
0—20
|
|
Q35.9
|
Cleft palate, unspecified
|
0—20
|
|
Q37.0
|
Cleft hard palate with bilateral cleft lip
|
0—20
|
|
Q37.1
|
Cleft hard palate with unilateral cleft lip
|
0—20
|
|
Q37.2
|
Cleft soft palate with bilateral cleft lip
|
0—20
|
|
Q37.3
|
Cleft soft palate with unilateral cleft lip
|
0—20
|
|
Q37.4
|
Cleft hard and soft palate with bilateral cleft lip
|
0—20
|
|
Q37.5
|
Cleft hard and soft palate with unilateral cleft lip
|
0—20
|
|
Q37.8
|
Unspecified cleft palate with bilateral cleft lip
|
0—20
|
|
Q37.9
|
Unspecified cleft palate with unilateral cleft lip
|
0—20
|
|
Q39.0
|
Atresia of esophagus without fistula
|
0—3
|
|
Q39.1
|
Atresia of esophagus with tracheo-esophageal fistula
|
0—3
|
|
Q39.2
|
Congenital tracheo-esophageal fistula without atresia
|
0—3
|
|
Q39.3
|
Congenital stenosis and stricture of esophagus
|
0—3
|
|
Q39.4
|
Esophageal web
|
0—3
|
|
Q42.0
|
Congenital absence, atresia and stenosis of rectum with fistula
|
0—5
|
|
Q42.1
|
Congen absence, atresia and stenosis of rectum without fistula
|
0—5
|
|
Q42.2
|
Congenital absence, atresia and stenosis of anus with fistula
|
0—5
|
|
Q42.3
|
Congenital absence, atresia and stenosis of anus without fistula
|
0—5
|
|
Q42.8
|
Congenital absence, atresia and stenosis of other parts of large intestine
|
0—5
|
|
Q42.9
|
Congenital absence, atresia and stenosis of large intestine, part unspecified
|
0—5
|
|
Q43.1
|
Hirschsprung’s disease
|
0—15
|
|
Q44.2
|
Atresia of bile ducts
|
0—20
|
|
Q44.3
|
Congenital stenosis and stricture of bile ducts
|
0—20
|
|
Q44.6
|
Cystic disease of liver
|
0—20
|
|
Q45.0
|
Agenesis, aplasia and hypoplasia of pancreas
|
0—5
|
|
Q45.1
|
Annular pancreas
|
0—5
|
|
Q45.3
|
Other congenital malformations of pancreas and pancreatic duct
|
0—5
|
|
Q45.8
|
Other specified congenital malformations of digestive system
|
0—10
|
|
Q60.1
|
Renal agenesis, bilateral
|
0—20
|
|
Q60.4
|
Renal hypoplasia, bilateral
|
0—20
|
|
Q60.6
|
Potter’s syndrome, with bilateral renal agenesis only
|
0—20
|
|
Q61.02
|
Congenital multiple renal cysts, bilateral only
|
0—20
|
|
Q61.19
|
Other polycystic kidney, infantile type, bilateral only
|
0—20
|
|
Q61.2
|
Polycystic kidney, adult type, bilateral only
|
0—20
|
|
Q61.3
|
Polycystic kidney, unspecified, bilateral only
|
0—20
|
|
Q61.4
|
Renal dysplasia, bilateral only
|
0—20
|
|
Q61.5
|
Medullary cystic kidney, bilateral only
|
0—20
|
|
Q61.9
|
Cystic kidney disease, unspecified, bilateral only
|
0—20
|
|
Q64.10
|
Exstrophy of urinary bladder, unspecified
|
0—20
|
|
Q64.12
|
Cloacal extrophy of urinary bladder
|
0—20
|
|
Q64.19
|
Other exstrophy of urinary bladder
|
0—20
|
|
Q75.0
|
Craniosynostosis
|
0—20
|
|
Q75.1
|
Craniofacial dysostosis
|
0—20
|
|
Q75.2
|
Hypertelorism
|
0—20
|
|
Q75.4
|
Mandibulofacial dysostosis
|
0—20
|
|
Q75.5
|
Oculomandibular dysostosis
|
0—20
|
|
Q75.8
|
Other congenital malformations of skull and face bones
|
0—20
|
|
Q77.4
|
Achondroplasia
|
0—1
|
|
Q77.6
|
Chondroectodermal dysplasia
|
0—1
|
|
Q77.8
|
Other osteochondrodysplasia with defects of growth of tubular bones and spine
|
0—1
|
|
Q78.0
|
Osteogenesis imperfecta
|
0—20
|
|
Q78.1
|
Polyostotic fibrous dysplasia
|
0—1
|
|
Q78.2
|
Osteopetrosis
|
0—1
|
|
Q78.3
|
Progressive diaphyseal dysplasia
|
0—1
|
|
Q78.4
|
Enchondromatosis
|
0—1
|
|
Q78.6
|
Multiple congenital exostoses
|
0—1
|
|
Q78.8
|
Other specified osteochondrodysplasias
|
0—1
|
|
Q78.9
|
Osteochondrodysplasia, unspecified
|
0—1
|
|
Q79.0
|
Congenital diaphragmatic hernia
|
0—1
|
|
Q79.1
|
Other congenital malformations of diaphragm
|
0—1
|
|
Q79.2
|
Exomphalos
|
0—1
|
|
Q79.3
|
Gastroschisis
|
0—1
|
|
Q79.4
|
Prune belly syndrome
|
0—1
|
|
Q79.59
|
Other congenital malformations of abdominal wall
|
0—1
|
|
Q89.7
|
Multiple congenital malformations, not elsewhere classified
|
0—10
|
|
R75
|
Inconclusive laboratory evidence of HIV
|
0—12 months
|
|
Z21
|
Asymptomatic human immunodeficiency virus infection status
|
0—20
|
|
Z99.11
|
Dependence on respirator (ventilator) status
|
1—64
|
|
Z99.2
|
Dependence on renal dialysis
|
21—64
|
